Clinical Trial Update: A Pilot Study of Metformin Treatment in Patients With Well-differentiated Neuroendocrine Tumors [Phase 2]

View source ↗

Summary

Pilot Phase 2 study evaluating metformin as treatment for patients with well-differentiated neuroendocrine tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Well-differentiated Neuroendocrine Tumor

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Instituto do Cancer do Estado de São Paulo | Conditions: Well-differentiated Neuroendocrine Tumors | Phase 2 | Status: UNKNOWN